https://www.selleckchem.com/products/unc6852.html
Radiation therapy has undergone significant technical development in the past decade. However, the complex therapy of intermediate-risk patients with organ-confined prostate carcinoma still poses many questions. Our retrospective study investigated the impact of selected components of the treatment process including radiotherapy, hormone deprivation, risk classification, and patients' response to therapy. The impact of delivered dose, planning accuracy, duration of hormone deprivation, risk classification, and the time to reach prostate
Like
Comment
Share
